StockOtters
StockOttersSupply Chain Map
Simcere Pharmaceutical Group Limited logo

Simcere Pharmaceutical Group Limited

2096.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
863
Cost of Revenue
170
Gross Profit
692
Gross Margin
80.2%
Operating Income
110
Operating Margin
12.8%
Net Income
95
Net Margin
11.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
176
EBITDA Margin
20.3%

2023

12/31/2023

Revenue
859
Cost of Revenue
211
Gross Profit
648
Gross Margin
75.4%
Operating Income
93
Operating Margin
10.8%
Net Income
93
Net Margin
10.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
141
EBITDA Margin
16.4%

2022

12/31/2022

Revenue
821
Cost of Revenue
172
Gross Profit
650
Gross Margin
79.1%
Operating Income
112
Operating Margin
13.6%
Net Income
121
Net Margin
14.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
106
EBITDA Margin
12.9%

2021

12/31/2021

Revenue
650
Cost of Revenue
140
Gross Profit
510
Gross Margin
78.4%
Operating Income
188
Operating Margin
29.0%
Net Income
196
Net Margin
30.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
55
EBITDA Margin
8.4%

2020

12/31/2020

Revenue
586
Cost of Revenue
117
Gross Profit
469
Gross Margin
80.0%
Operating Income
120
Operating Margin
20.6%
Net Income
87
Net Margin
14.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
99
EBITDA Margin
16.8%